Homeodomain interacting protein kinase 2 activation compromises endothelial cell response to laminar flow: Protective role of p21waf1,cip1,sdi1

PLoS ONE

Volumn 4, Issue 8, 2009, Pages

  Mattiussi, Stefania ^a   Lazzari, Chiara ^b   Truffa, Silvia ^a,c   Antonnini, Annalisa ^a   Soddu, Silvia ^b   Capogrossi, Maurizio C ^a   Gaetano, Carlo ^a  

^a LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^b REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^c SAN DIEGO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATR PROTEIN; BLEOMYCIN; CYCLIN DEPENDENT KINASE INHIBITOR 1; FREE RADICAL; HOMEODOMAIN INTERACTING PROTEIN KINASE 2; INDUCIBLE NITRIC OXIDE SYNTHASE; PROTEIN P53; S [2 (1 IMINOETHYLAMINO)ETHYL]HOMOCYSTEINE; CARRIER PROTEIN; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; HIPK2 PROTEIN, HUMAN; PRIMER DNA; PROTEIN SERINE THREONINE KINASE; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; ARTICLE; CARDIOVASCULAR DISEASE; CELL CULTURE; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; ENDOTHELIAL DYSFUNCTION; GENOTOXICITY; HUMAN; HUMAN CELL; LAMINAR FLOW; PATHOGENESIS; PROTEIN EXPRESSION; RNA INTERFERENCE; SHEAR STRESS; SIGNAL TRANSDUCTION; CYTOLOGY; DRUG EFFECT; ENZYME ACTIVATION; ENZYMOLOGY; METABOLISM; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

APOPTOSIS; BASE SEQUENCE; BLEOMYCIN; BLOTTING, WESTERN; CARRIER PROTEINS; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA PRIMERS; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; HUMANS; POLYMERASE CHAIN REACTION; PROTEIN-SERINE-THREONINE KINASES; REACTIVE OXYGEN SPECIES; RNA INTERFERENCE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 68749092860     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0006603     Document Type: Article

References (33)

1. Bartling B, Tostlebe H, Darmer D, Holtz J, Silber RE, et al. (2000) Shear stress-dependent expression of apoptosis-regulating genes in endothelial cells. Biochem Biophys Res Commun 278: 740-746.
2. Shyy JY, Chien S (2002) Role of integrins in endothelial mechanosensing of shear stress. Circ Res 91: 769-775.
3. Mattiussi S, Turrini P, Testolin L, Martelli F, Zaccagnini G, et al. (2004) p21(Waf1/Cip1/Sdi1) mediates shear stress-dependent antiapoptotic function. Cardiovasc Res 61: 693-704.
4. Mattiussi S, Matsumoto K, Illi B, Martelli F, Capogrossi MC, et al. (2006) Papilloma protein E6 abrogates shear stress-dependent survival in human endothelial cells: evidence for specialized functions of paxillin. Cardiovasc Res 70: 578-588.
5. Lin K, Hsu PP, Chen BP, Yuan S, Usami S, et al. (2000) Molecular mechanism of endothelial growth arrest by laminar shear stress. Proc Natl Acad Sci U S A 97: 9385-9389.
6. Akimoto S, Mitsumata M, Sasaguri T, Yoshida Y (2000) Laminar shear stress inhibits vascular endothelial cell proliferation by inducing cyclin-dependent kinase inhibitor p21(Sdi1/Cip1/Waf1). Circ Res 86: 185-190.
7. Harrison DG, Widder J, Grumbach I, Chen W, Weber M, et al. (2006) Endothelial mechanotransduction, nitric oxide and vascular inflammation. J Intern Med 259: 351-363.
8. Dimmeler S, Hermann C, Galle J, Zeiher AM (1999) Upregulation of superoxide dismutase and nitric oxide synthase mediates the apoptosis-suppressive effects of shear stress on endothelial cells. Arterioscler Thromb Vasc Biol 19: 656-664.
9. Hermann C, Zeiher AM, Dimmeler S (1997) Shear stress inhibits H2O2-induced apoptosis of human endothelial cells by modulation of the glutathione redox cycle and nitric oxide synthase. Arterioscler Thromb Vasc Biol 17: 3588-3592.
10. Moncada S, Higgs EA (2006) Nitric oxide and the vascular endothelium. Handb Exp Pharmacol. pp 213-254.
11. Pacher P, Beckman JS, Liaudet L (2007) Nitric oxide and peroxynitrite in health and disease. Physiol Rev 87: 315-424.
12. Das U (2002) A radical approach to cancer. Med Sci Monit 8: RA79-92.
13. Mailloux A, Grenet K, Bruneel A, Beneteau-Burnat B, Vaubourdolle M, et al. (2001) Anticancer drugs induce necrosis of human endothelial cells involving both oncosis and apoptosis. Eur J Cell Biol 80: 442-449.
14. Lazo JS (1986) Endothelial injury caused by antineoplastic agents. Biochem Pharmacol 35: 1919-1923.
15. Martin WJ 2nd, Kachel DL (1987) Bleomycin-induced pulmonary endothelial cell injury: evidence for the role of iron-catalyzed toxic oxygen-derived species. J Lab Clin Med 110: 153-158.
16. Chen J, Stubbe J (2005) Bleomycins: towards better therapeutics. Nat Rev Cancer 5: 102-112.
17. Meulmeester E, Jochemsen AG (2008) p53: a guide to apoptosis. Curr Cancer Drug Targets 8: 87-97.
18. Dauth I, Kruger J, Hofmann TG (2007) Homeodomain-interacting protein kinase 2 is the ionizing radiation-activated p53 serine 46 kinase and is regulated by ATM. Cancer Res 67: 2274-2279.
19. Dimmeler S, Haendeler J, Rippmann V, Nehls M, Zeiher AM (1996) Shear stress inhibits apoptosis of human endothelial cells. FEBS Lett 399: 71-74.
20. Fragkos M, Jurvansuu J, Beard P (2009) H2AX is required for cell cycle arrest via the p53/p21 pathway. Mol Cell Biol.
21. Hall MC, Li Y, Pong RC, Ely B, Sagalowsky AI, et al. (2000) The growth inhibitory effect of p21 adenovirus on human bladder cancer cells. J Urol 163: 1033-1038.
22. Fisslthaler B, Dimmeler S, Hermann C, Busse R, Fleming I (2000) Phosphorylation and activation of the endothelial nitric oxide synthase by fluid shear stress. Acta Physiol Scand 168: 81-88.
23. Alderton WK, Cooper CE, Knowles RG (2001) Nitric oxide synthases: structure, function and inhibition. Biochem J 357: 593-615.
24. Gomes A, Fernandes E, Lima JL (2005) Fluorescence probes used for detection of reactive oxygen species. J Biochem Biophys Methods 65: 45-80.
25. Eiserich JP, Patel RP, O'Donnell VB (1998) Pathophysiology of nitric oxide and related species: free radical reactions and modification of biomolecules. Mol Aspects Med 19: 221-357.
26. Gartel AL, Radhakrishnan SK (2005) Lost in transcription: p21 repression, mechanisms, and consequences. Cancer Res 65: 3980-3985.
27. Colman MS, Afshari CA, Barrett JC (2000) Regulation of p53 stability and activity in response to genotoxic stress. Mutat Res 462: 179-188.
28. Yamawaki H, Pan S, Lee RT, Berk BC (2005) Fluid shear stress inhibits vascular inflammation by decreasing thioredoxin-interacting protein in endothelial cells. J Clin Invest 115: 733-738.
29. Colussi C, Gurtner A, Rosati J, Illi B, Ragone G, et al. (2009) Nitric oxide deficiency determines global chromatin changes in Duchenne muscular dystrophy. Faseb J.
30. Colussi C, Mozzetta C, Gurtner A, Illi B, Rosati J, et al. (2008) HDAC2 blockade by nitric oxide and histone deacetylase inhibitors reveals a common target in Duchenne muscular dystrophy treatment. Proc Natl Acad Sci U S A 105: 19183-19187.
31. Illi B, Dello Russo C, Colussi C, Rosati J, Pallaoro M, et al. (2008) Nitric oxide modulates chromatin folding in human endothelial cells via protein phosphatase 2A activation and class II histone deacetylases nuclear shuttling. Circ Res 102: 51-58.
32. Sullivan R, Graham CH (2008) Chemosensitization of cancer by nitric oxide. Curr Pharm Des 14: 1113-1123.
33. Genovese T, Cuzzocrea S, Di Paola R, Failla M, Mazzon E, et al. (2005) Inhibition or knock out of inducible nitric oxide synthase result in resistance to bleomycin-induced lung injury. Respir Res 6: 58.